Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

177690 Press Releases
DateTitleCompany
24 Aug 17 Committee for Children Launches First-of-Its-Kind Digital Social-Emotional Learning Curriculum for Middle Schoolers Committee for Children,
Published by
PR Newswire
24 Aug 17 Aromatherapy Diffusers Market Size Worth $2.68 Billion by 2025: Grand View Research, Inc. Grand View Research, Inc.,
Published by
PR Newswire
24 Aug 17 AroCell AB: Interim report, Q2 2017 Published by
GlobeNewswire
24 Aug 17 Novartis Kisqali® (ribociclib) receives EU approval as first-line treatment for HR+/HER2- locally advanced or metastatic breast cancer in combination with any aromatase inhibitor Published by
GlobeNewswire
24 Aug 17 Novartis appoints Bertrand Bodson as Chief Digital Officer Published by
GlobeNewswire
24 Aug 17 Weifa ASA: Karo Pharma AB announces a recommended voluntary cash offer to acquire all shares in Weifa ASA Weifa ASA,
Published by
GlobeNewswire
24 Aug 17 Novartis Kisqali® (ribociclib) receives EU approval as first-line treatment for HR+/HER2- locally advanced or metastatic breast cancer in combination with any aromatase inhibitor Novartis International AG,
Published by
GlobeNewswire
24 Aug 17 Novartis appoints Bertrand Bodson as Chief Digital Officer Novartis International AG,
Published by
GlobeNewswire
24 Aug 17 Weifa ASA: mandatory notification of trade and disclosure of shareholding Weifa ASA,
Published by
GlobeNewswire
24 Aug 17 Acarix interim report, January - June 2017: CADScor® System commercially available and first sales announced Acarix AB,
Published by
GlobeNewswire
24 Aug 17 Otsuka and Mylan Announce License Agreement to Commercialize Delamanid (Deltyba™) for Multidrug-Resistant Tuberculosis (MDR-TB) in High-Burden Countries Mylan N.V.,
Published by
PR Newswire
24 Aug 17 Chugai's Emicizumab Receives Priority Review Designation by FDA for Hemophilia A with Inhibitors Chugai Pharmaceutical Co., Ltd.,
Published by
Business Wire
24 Aug 17 Takeda Submits a New Drug Application for Vedolizumab for the Treatment of Moderately to Severely Ulcerative Colitis in Japan Takeda ,
Published by
PharmiWeb.com
24 Aug 17 Baxter and ASPEN Announce Collaboration to Help Reduce Malnutrition Through Appropriate Use of Parenteral Nutrition Therapy Baxter ,
Published by
PharmiWeb.com
24 Aug 17 Alliance Foundation Trials Opens Global Trial Investigating First-in-Class Palbociclib in HR+, HER2+ Metastatic Breast Cancer The Alliance Foundation Trials,
Published by
PharmiWeb.com
24 Aug 17 Bayer will continue to work constructively with the European Commission Bayer ,
Published by
PharmiWeb.com
24 Aug 17 First Patient Dosed in Phase 3 MORPHO Trial Evaluating Gilteritinib as Maintenance Therapy Following Hematopoietic Stem Cell Transplant in Patients with FLT3 Mutation-positive Acute Myeloid Leukemia Astellas Pharma ,
Published by
PharmiWeb.com
24 Aug 17 Macrophage Pharma Limited Extends Series A Round to Include New Investor Merck Ventures Macrophage,
Published by
PharmiWeb.com
24 Aug 17 FDA Grants Priority Review to Genentech’s Emicizumab for Hemophilia A with Inhibitors Genentech,
Published by
Business Wire
24 Aug 17 argenx reports second quarter business update and half-year 2017 financial results argenx SE,
Published by
GlobeNewswire
24 Aug 17 Probiodrug AG to Publish First Half 2017 Results on 31 August 2017 Probiodrug,
Published by
GlobeNewswire
24 Aug 17 Targovax ASA: Second quarter and first half 2017 results Targovax ASA,
Published by
GlobeNewswire
24 Aug 17 IBA SA : IBA Reports Half Year Results for 2017 IBA SA,
Published by
GlobeNewswire
24 Aug 17 Probiodrug AG to Publish First Half 2017 Results on 31 August 2017 Published by
GlobeNewswire
24 Aug 17 Targovax ASA: Second quarter and first half 2017 results Published by
GlobeNewswire
24 Aug 17 argenx reports second quarter business update and half-year 2017 financial results Published by
GlobeNewswire
24 Aug 17 Scientists discover common Diabetes drug reduces sight-threatening rise in brain pressure University of Birmingham, UK,
Published by
PharmiWeb.com
23 Aug 17 Misonix Appoints Joseph Dwyer as Chief Financial Officer Published by
GlobeNewswire
23 Aug 17 TESARO? Announces Participation at Four Investor Conferences Published by
GlobeNewswire
23 Aug 17 ABELSoft Inc. Celebrates 40 Years in Business Published by
GlobeNewswire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.